VAERS Explorer
Back to explore

Report #2827108

Received Feb 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
Jan 8, 2025
Onset
Jan 8, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (3)

Inappropriate schedule of product administrationIncorrect dose administeredProduct preparation error

Symptom narrative

The patient received a prior dose of Shingrix back on September 26th 2023 (unknown lot number and expiration date), and the second dose was given on January 8th 2025.; Second dose was the one who was mixed with a different diluent,; Second dose was the one who was mixed with a different diluent,; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 26-SEP-2023). On 08-JAN-2025, the patient received the 2nd dose of Shingrix. On 08-JAN-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: The patient received a prior dose of Shingrix back on September 26th 2023 (unknown lot number and expiration date), and the second dose was given on January 8th 2025.), wrong solution used in drug reconstitution (Verbatim: Second dose was the one who was mixed with a different diluent,) and inappropriate dose of vaccine administered (Verbatim: Second dose was the one who was mixed with a different diluent,). The outcome of the drug dose administration interval too long, wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 24-JAN-2025 The medical assistant reported that a patient received prior dose of Shingrix back on September 26th 2023 (unknown lot number and expiration date), and the second dose was given on January 8th 2025, which led to drug dose administration interval too long. Second dose was the one who was mixed with a different diluent, and the diluent pertains to an MMR vaccine, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.